MNT daily newsletter - February 09, 2019

Medical News Today

Dear S.C.T.C,

Welcome to today's MNT newsletter, containing the most recent headlines from your chosen news categories.


Anxiety / Stress
Could this chemical help explain anxiety?
A new study attempts to unpick the role that glutamate might have in anxiety. The findings could eventually form the basis of more effective treatments.


Biology / Biochemistry
Blocking fatty acids slows prostate cancer progression
New research in mice finds that fatty acids fuel prostate tumor growth and that blocking the uptake of fatty acids slows cancer progression.


Cancer / Oncology
Blocking fatty acids slows prostate cancer progression
New research in mice finds that fatty acids fuel prostate tumor growth and that blocking the uptake of fatty acids slows cancer progression.


Neurology / Neuroscience
Could this chemical help explain anxiety?
A new study attempts to unpick the role that glutamate might have in anxiety. The findings could eventually form the basis of more effective treatments.


Prostate / Prostate Cancer
Blocking fatty acids slows prostate cancer progression
New research in mice finds that fatty acids fuel prostate tumor growth and that blocking the uptake of fatty acids slows cancer progression.


Psychology / Psychiatry
Could this chemical help explain anxiety?
A new study attempts to unpick the role that glutamate might have in anxiety. The findings could eventually form the basis of more effective treatments.


Chat with MNT on Facebook Messenger

Get the latest MNT news in Facebook Messenger. Chat with us now!

Just send us a message from our Facebook page.

Alternatively, use this link to chat directly on Messenger.


You are receiving this newsletter because you subscribed through your MNT account on our web site, Medical News Today. If you wish to alter any of your subscription details (name, email address etc) or chosen news categories, please log into log into your newsletter preferences page.

To unsubscribe from these newsletters immediately, please click here.



No comments:

Post a Comment